Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus
- 5 April 2001
- journal article
- research article
- Published by Springer Nature in Nature Cell Biology
- Vol. 3 (5) , 445-452
- https://doi.org/10.1038/35074506
Abstract
The alternative product of the human INK4a/ARF locus, p14ARF, has the potential to act as a tumour suppressor by binding to and inhibiting the p53 antagonist MDM2. Current models propose that ARF function depends on its ability to sequester MDM2 in the nucleolus. Here we describe situations in which stabilization of MDM2 and p53 occur without relocalization of endogenous MDM2 from the nucleoplasm. Conversely, forms of ARF that do not accumulate in the nucleolus retain the capacity to stabilize MDM2 and p53. We therefore propose that nucleolar localization is not essential for ARF function but may enhance the availability of ARF to inhibit MDM2.Keywords
This publication has 36 references indexed in Scilit:
- Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localizationOncogene, 2000
- An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoOncogene, 2000
- Immunolocalization of Human p14ARF to the Granular Component of the Interphase NucleolusExperimental Cell Research, 2000
- p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblastsOncogene, 1999
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Aggresomes: A Cellular Response to Misfolded ProteinsThe Journal of cell biology, 1998
- Regulation of p53 stability by Mdm2Nature, 1997
- Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16 INK4a but not by the alternative reading frame protein p19 ARFProceedings of the National Academy of Sciences, 1997
- Chapter 14 Methods Used to Study Structure and Function of the NucleolusPublished by Elsevier ,1997
- Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response elementCell, 1992